These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC. Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735 [Abstract] [Full Text] [Related]
34. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar). Selby CD, Ladusans EJ, Smith PG. Br Med J (Clin Res Ed); 1985 Jan 12; 290(6462):113-4. PubMed ID: 3155635 [No Abstract] [Full Text] [Related]
35. Liver damage associated with fansidar. Wejstal R, Lindberg J, Malmvall BE, Norkrans G. Lancet; 1986 Apr 12; 1(8485):854-5. PubMed ID: 2870335 [No Abstract] [Full Text] [Related]
36. Adverse reactions to pyrimethamine/sulfadoxine. Koch-Weser J, Hodel C, Leimer R, Styk S. Lancet; 1982 Dec 25; 2(8313):1459. PubMed ID: 6129527 [No Abstract] [Full Text] [Related]
37. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar). Zitelli BJ, Alexander J, Taylor S, Miller KD, Howrie DL, Kuritsky JN, Perez TH, Van Thiel DH. Ann Intern Med; 1987 Mar 25; 106(3):393-5. PubMed ID: 2949680 [Abstract] [Full Text] [Related]
38. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. Steffen R, Somaini B. Lancet; 1986 Mar 15; 1(8481):610. PubMed ID: 2869315 [No Abstract] [Full Text] [Related]